Free Trial

Treatt (TET) Competitors

Treatt logo
GBX 226.50 +7.00 (+3.19%)
As of 11:50 AM Eastern

TET vs. SCPA, ESNT, SYNT, ZTF, IOF, WCH, ITX, DCTA, HAYD, and BIOM

Should you be buying Treatt stock or one of its competitors? The main competitors of Treatt include Scapa Group (SCPA), Essentra (ESNT), Synthomer (SYNT), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Haydale Graphene Industries (HAYD), and Biome Technologies (BIOM). These companies are all part of the "specialty chemicals" industry.

Treatt vs.

Scapa Group (LON:SCPA) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, community ranking, analyst recommendations, valuation, institutional ownership and dividends.

Treatt has a net margin of 7.88% compared to Scapa Group's net margin of 0.00%. Treatt's return on equity of 8.09% beat Scapa Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Scapa GroupN/A N/A N/A
Treatt 7.88%8.09%6.72%

Scapa Group received 33 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 56.27% of users gave Scapa Group an outperform vote.

CompanyUnderperformOutperform
Scapa GroupOutperform Votes
193
56.27%
Underperform Votes
150
43.73%
TreattOutperform Votes
160
68.97%
Underperform Votes
72
31.03%

50.9% of Treatt shares are owned by institutional investors. 13.4% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Treatt has a consensus price target of GBX 650, indicating a potential upside of 186.98%. Given Treatt's stronger consensus rating and higher probable upside, analysts plainly believe Treatt is more favorable than Scapa Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Scapa Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Treatt
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Treatt has lower revenue, but higher earnings than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scapa Group£281.80M0.00N/A-£29.30N/A
Treatt£142.31M0.96£11.22M£18.5112.24

In the previous week, Treatt had 2 more articles in the media than Scapa Group. MarketBeat recorded 2 mentions for Treatt and 0 mentions for Scapa Group. Scapa Group's average media sentiment score of 0.00 equaled Treatt'saverage media sentiment score.

Company Overall Sentiment
Scapa Group Neutral
Treatt Neutral

Summary

Treatt beats Scapa Group on 12 of the 14 factors compared between the two stocks.

Get Treatt News Delivered to You Automatically

Sign up to receive the latest news and ratings for TET and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TET vs. The Competition

MetricTreattSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£136.95M£8.18B£2.97B£2.47B
Dividend Yield2.00%3.58%5.22%4.95%
P/E Ratio12.2412.2075.81129.48
Price / Sales0.9647.3123,032,091,497,815,300.00231,299.35
Price / Cash165.4319.2524.3227.98
Price / Book0.975.075.224.44
Net Income£11.22M£220.83M£155.11M£5.80B
7 Day Performance6.59%2.59%5.64%3.14%
1 Month Performance-41.02%5.64%1.86%3.82%
1 Year Performance-51.81%-19.11%16.49%102.57%

Treatt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TET
Treatt
2.829 of 5 stars
GBX 226.50
+3.2%
GBX 650
+187.0%
-53.4%£136.95M£142.31M12.24350Dividend Increase
High Trading Volume
SCPA
Scapa Group
N/AN/AN/AN/A£402.98M£281.80M-7.321,461
ESNT
Essentra
2.4235 of 5 stars
GBX 93.20
-0.2%
GBX 206.67
+121.7%
-48.7%£267.89M£309.74M76.78350Negative News
SYNT
Synthomer
2.1665 of 5 stars
GBX 84.90
+0.4%
GBX 225
+165.0%
-67.4%£139.22M£1.87B-1.704,200
ZTF
Zotefoams
N/AGBX 249
-1.2%
N/A-34.4%£119.76M£131.66M12.06549Gap Up
IOF
Iofina
2.4031 of 5 stars
GBX 20.60
-0.7%
GBX 36.25
+76.0%
-1.6%£49.46M£61.34M14.4695Analyst Forecast
News Coverage
WCH
Wilmcote Holdings plc (WCH.L)
N/AN/AN/AN/A£20.13MN/A-5.003
ITX
Itaconix
N/AGBX 108
+0.9%
N/A-25.0%£14.57M£5.28M-9.7817High Trading Volume
DCTA
Directa Plus
N/AGBX 7.50
+3.4%
N/A-61.3%£10.09M£20.29M-1.33187Gap Up
HAYD
Haydale Graphene Industries
N/AGBX 0.13
-1.5%
N/A-70.7%£5M£14.20M-0.2867
BIOM
Biome Technologies
N/AGBX 9.20
-4.3%
N/A-90.0%£4.74M£78.36M-0.2727

Related Companies and Tools


This page (LON:TET) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners